MURINE MUCOSAL T-CELLS HAVE VIP RECEPTORS FUNCTIONALLY DISTINCT FROM THOSE ON INTESTINAL EPITHELIAL-CELLS

被引：35

作者：

BLUM, AM ^{[1
]}

MATHEW, R ^{[1
]}

COOK, GA ^{[1
]}

METWALI, A ^{[1
]}

FELMAN, R ^{[1
]}

WEINSTOCK, JV ^{[1
]}

机构：

[1] UNIV IOWA,COLL MED,DEPT INTERNAL MED,DIV GASTROENTEROL HEPATOL,4607 JCP,IOWA CITY,IA 52242

来源：

JOURNAL OF NEUROIMMUNOLOGY | 1992年 / 39卷 / 1-2期

关键词：

IMMUNOREGULATION; NEUROPEPTIDE; INTERLEUKIN-5;

D O I：

10.1016/0165-5728(92)90179-O

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Reports suggest that vasoactive intestinal peptide (VIP) binds to lymphocytes and modulates immune responses. The intestines are richly innervated with VIP-producing nerves. Thus, VIP from nerves or other sources may participate in mucosal immunoregulation. To explore this hypothesis further, murine intestinal mucosa inflammatory cells were scrutinized for functional VIP receptors. An [I-125]VIP competitive binding assay characterized VIP receptors. Unfractionated lamina propria inflammatory cells bound [I-125]VIP specifically. This binding was abrogated by T cell depletion. The VIP receptor on lamina propria T cells was of a single class with a K(d) Of 9.08 X 10(-9) M. It bound PHI and other peptide analogs poorly. The intestinal epithelial cell had a high-affinity VIP receptor (K(d) 4.17 X 10(-10) M) that bound one VIP analog with moderate affinity. Both VIP and ConA stimulated mucosal inflammatory cells to release interleukin-5 (IL-5). Mucosal inflammatory cells depleted of T cells did not release IL-5 in response to VIP or ConA. It is concluded that: (1) some murine mucosal T lymphocytes have VIP receptors that may be distinct from those displayed on mucosal epithelial cells; (2) VIP affects mucosal T lymphocyte function.

引用

页码：101 / 108

页数：8

共 30 条

[1] SELECTIVE LOCALIZATION OF VASOACTIVE-INTESTINAL-PEPTIDE AND SUBSTANCE-P IN HUMAN EOSINOPHILS
ALIAKBARI, J
SREEDHARAN, SP
TURCK, CW
GOETZL, EJ
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 148 (03) : 1440 - 1445
[2] BEAGLEY KW, 1988, J IMMUNOL, V141, P2035
[3] Bland P W, 1987, Adv Exp Med Biol, V216A, P219
[4] BROOKER G, 1986, J CYCLIC NUCL PROT, V11, P113
[5] JAMES SP, 1990, J IMMUNOL, V144, P1251
[6] LEBMAN DA, 1988, J IMMUNOL, V141, P2050
[7] MURINE EOSINOPHIL DIFFERENTIATION FACTOR - AN EOSINOPHIL-SPECIFIC COLONY-STIMULATING FACTOR WITH ACTIVITY FOR HUMAN-CELLS
LOPEZ, AF
BEGLEY, CG
WILLIAMSON, DJ
WARREN, DJ
VADAS, MA
SANDERSON, CJ
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (05) : 1085 - 1099
[8] THE VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTOR - RECENT DATA AND HYPOTHESIS
LUIS, J
MARTIN, JM
ELBATTARI, A
MARVALDI, J
PICHON, J
[J]. BIOCHIMIE, 1988, 70 (10) : 1311 - 1322
[9] LACK OF INDUCTION OF SUPPRESSOR T-CELLS BY INTESTINAL EPITHELIAL-CELLS FROM PATIENTS WITH INFLAMMATORY BOWEL-DISEASE
MAYER, L
EISENHARDT, D
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (04) : 1255 - 1260
[10] ODORISIO MS, 1987, FASEB J, V46, P192

← 1 2 3 →